Steven Cohen acquired 924 Thousand Genmab shares worth $19.2 Million. That's 0.05% of their equity portfolio (353rd largest holding). The first Genmab trade was made in Q1 2021. Since then Steven Cohen bought shares six more times and sold shares on six occasions. The investor's estimated purchase price is $19.5 Million, resulting in a loss of 1.7%.